You are viewing the site in preview mode

Skip to main content

Table 3 Sub-analyses of CGRP levels in plasma and CSF depending on headache existence, migraine phenotype, and chronicity

From: Calcitonin gene-related peptide in newly diagnosed idiopathic intracranial hypertension: a prospective, cross-sectional, case-control study of cerebrospinal fluid and plasma

 

Plasma (pmol/L)

p-value

CSF (pmol/L)

p-value

Comparison 1, mean (± SD)

    

IIH with headache

157 ± 87, n = 80

 

48 ± 16, n = 75

 

Non-IIH with chronic migraine

159 ± 88, n = 28

 

49 ± 14, n = 26

 

Healthy controls

167 ± 66, n = 36

0.834

47 ± 12, n = 31

0.836

Comparison 2, median (IQR)

    

IIH with headache

160 (118–189), n = 80

 

45 (41–63), n = 75

 

IIH without headache

129 (87–205), n = 7

0.708

47 (37–58), n = 7

0.752

Comparison 3, mean (± SD)

    

IIH with chronic migraine

174 ± 92, n = 26

 

48 ± 16, n = 25

 

Healthy controls without migraine

168 ± 66, n = 30

0.803

46 ± 13, n = 26

0.755